close
close

TC BioPharm announces the grant of a European patent for the use of modified gamma delta cells for the treatment of cancer and viral indications


TC BioPharm announces the grant of a European patent for the use of modified gamma delta cells for the treatment of cancer and viral indications

EDINBURGH, Scotland, 28 August 2024 /PRNewswire/ — TC BioPharm (Holdings) PLC (“TC BioPharm” or the “Company”) (NASDAQ: TCBP), a clinical-stage biotechnology company developing a platform for allogeneic gamma delta T cell therapies for cancer and other indications, today announced that it has been granted a patent from the European Patent Office (EPO) for the use […]